Nothing Special   »   [go: up one dir, main page]

SE0301794D0 - New use III - Google Patents

New use III

Info

Publication number
SE0301794D0
SE0301794D0 SE0301794A SE0301794A SE0301794D0 SE 0301794 D0 SE0301794 D0 SE 0301794D0 SE 0301794 A SE0301794 A SE 0301794A SE 0301794 A SE0301794 A SE 0301794A SE 0301794 D0 SE0301794 D0 SE 0301794D0
Authority
SE
Sweden
Prior art keywords
new use
use iii
iii
ibs
piperidyl
Prior art date
Application number
SE0301794A
Other languages
Swedish (sv)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301794A priority Critical patent/SE0301794D0/en
Publication of SE0301794D0 publication Critical patent/SE0301794D0/en
Priority to PCT/SE2004/000961 priority patent/WO2004110446A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The present invention relates to the use of piperidyl- or piperazinyl-substituted-1,2,3,4-tetrahydronaphthalene derivatives for the treatment of irritable bowel syndrome (IBS).
SE0301794A 2003-06-19 2003-06-19 New use III SE0301794D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301794A SE0301794D0 (en) 2003-06-19 2003-06-19 New use III
PCT/SE2004/000961 WO2004110446A1 (en) 2003-06-19 2004-06-16 Use of tetrahydronaphtalene derivatives for the treatment of ibs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301794A SE0301794D0 (en) 2003-06-19 2003-06-19 New use III

Publications (1)

Publication Number Publication Date
SE0301794D0 true SE0301794D0 (en) 2003-06-19

Family

ID=27607359

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301794A SE0301794D0 (en) 2003-06-19 2003-06-19 New use III

Country Status (2)

Country Link
SE (1) SE0301794D0 (en)
WO (1) WO2004110446A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179041A (en) * 2008-12-10 2020-10-26 Theravance Biopharma R&D Ip Llc Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151419T1 (en) * 1991-02-08 1997-04-15 Lilly Co Eli RING-SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALINES
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9601110D0 (en) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9702799D0 (en) * 1997-07-25 1997-07-25 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2004110446A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
DK1682530T3 (en) Pyrrole-substituted indoles as inhibitors of PAI-1
CY1110064T1 (en) FENYL-PIPERAZININE PRODUCTS AS SEROTONIN REFLECTION INHIBITORS
DK1337518T3 (en) Piperazinylpyrazine Compounds as Antagonists of the Serotonin-5-HT2 Receptor
NO20034289L (en) N- (2-arylethyl) benzylamines as antagonists of the 5-HT6 receptor
EA200601555A1 (en) Substituted indazole-glucosides
EA200601554A1 (en) SUBSTITUTED INDOL-O-GLUCOSIDES
EA200601553A1 (en) SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES
DE60230890D1 (en) INDOLICINE AS KINASEPROTEINHEMMER
EA200501928A1 (en) Pyrrolodihydroisoquinols as inhibitors of PDE10
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
NO20051260L (en) Aryl-substituted diazabicycloalkanes as nicotine acetylcholine agonists
EA200301142A1 (en) DERIVATIVES OF HETEROCYCLILOXY-, -TIOOXY-AND-AMINOBENZAZOL AS A LYHANDS OF 5-HYDROXITRIPTAMINE-6
EA200700365A1 (en) INDOL-2-CARBOXAMIDINE DERIVATIVES AS ANTAGONISTS OF NMDA RECEPTOR
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
NO20081621L (en) Tetrahydroquinolines, synthesis and intermediates
ATE542796T1 (en) N-SULFONYLCARBOXIMIDAMIDE COMPOUNDS AS APOPTOSIS PROMOTERS
DE60316984D1 (en) BENZOYLSULFONAMIDE AS ANTITUMOR MEDIUM
EA200700550A1 (en) DERIVATIVES OF ALKYLIDENTETRAHYDRONAPTALINE, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
SE0103710D0 (en) Compounds
EA200300988A1 (en) DERIVATIVES OF PHENYL-HETEROCYCLINE ETHERS AS AN INHIBITORS OF REVERSE CAPTURE OF SEROTONIN
DE60316128D1 (en) N-sulfonylurea APOPTOSIS PROMOTERS
NO20080839L (en) Isotope-substituted proton pump inhibitors
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
SE0301794D0 (en) New use III
ATE374751T1 (en) 3,4-DIHYDRO-1H-QUINOLINE-2-ONE DERIVATIVES AS NOREPINEPHRINE RUPUP INHIBITORS